Melatonina
Anno: 1993
-
Riferimento:Int J Biochem. 1993 Mar;25(3):441-4.Azione della melatonina:Mlt (200 microM) affect selectively the processes of lymphoblastoid cell growth.Target:Inhibition of [3H]thymidine incorporation.
-
Titolo: Breast cancer and electric powerRiferimento:Biomed Pharmacother. 1993;47(10):435-8. Review.Azione della melatonina:These can reduce nocturnal melatonin production.Target:Light-at-night/electromagnetic fields
-
Riferimento:Biomed Pharmacother. 1993;47(10):425-7. ReviewAzione della melatonina:Pineal function is suppressed by light-at-night(LAN) 60-Hz electric fields suppress the nocturnal rise in pineal melatonin production.Target:Electromagnetic fields Light-at-night
-
Riferimento:Int J Biochem. 1993 Mar;25(3):441-4.Azione della melatonina:Affect selectively the processes of lymphoblastoid cell growth.Target:200 microM in vitro.
-
Riferimento:Br J Cancer.1993 Jun;67(6):1404-7.Azione della melatonina:The immunotherapy with low-dose IL-2 plus MLT (50mg/day orally) is a new well tolerated and effective therapy of advanced tumours of digestive tract.Target:Interleukin 2 (IL-2) plus MLT.
-
Titolo: Vitiligo: where do we stand?Riferimento:Pigment Cell Res. 1993 Mar;6(2):61-72.Azione della melatonina:Abnormalities in a putative melatonin receptor on melanocytes.Target:Several different pathogenetic mechanisms.
-
Riferimento:Eur J Cancer. 1993;29A(2):185-9.Azione della melatonina:Neuroimmunotherapy with low-dose IL-2 and MLT (50mg/day orally) is a biologically active and well tolerated strategy, capable of determining an apparent control of tumour growth in patients with advanced solid neoplasms.Target:Interleukin 2 (IL-2) plus .MLT
-
Riferimento:Dtsch Med Wochenschr. 1983 Mar 25;108(12):470-4. Review.Azione della melatonina:No abstract available.Target:No abstract available.
-
Riferimento:Environ Health Perspect. 1993 Dec;101 Suppl 4:93-100.Azione della melatonina:Effects on: DNA transcription and translation, calcium balance in cells, pineal production of mlt.Target:Electromagnetic fields (EMF)
-
Riferimento:Int J Oncol. 1993 Oct;3(4):687-94.Azione della melatonina:Antimitotic actions of melatonin(10(-8)-10(-11) M) may be mediated through the suppression of the estrogen-response pathway of MCF-7 cells.Target:Estrogen receptor (ER)